LAZARD ASSET MANAGEMENT LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$123
-10.2%
4,350
-7.5%
0.00%
Q4 2022$137
-99.9%
4,703
+8.6%
0.00%
Q3 2022$114,000
-40.6%
4,3300.0%0.00%
Q2 2022$192,000
+62.7%
4,330
+80.1%
0.00%
Q1 2022$118,000
-3.3%
2,404
-0.0%
0.00%
Q4 2021$122,000
+1.7%
2,405
+11.5%
0.00%
Q3 2021$120,000
+62.2%
2,157
+34.0%
0.00%
Q4 2020$74,000
+1380.0%
1,610
+1208.9%
0.00%
Q3 2020$5,000
-91.8%
123
-90.4%
0.00%
Q2 2020$61,000
-99.7%
1,277
-99.6%
0.00%
-100.0%
Q2 2018$24,388,000
+42.7%
322,340
-0.6%
0.04%
+44.8%
Q1 2018$17,085,000
-13.0%
324,257
-11.8%
0.03%
-14.7%
Q4 2017$19,631,000
-6.4%
367,497
+4.5%
0.03%
-10.5%
Q3 2017$20,973,000
-4.5%
351,673
+26.4%
0.04%
-7.3%
Q2 2017$21,953,000
+990.6%
278,282
+1046.4%
0.04%
+925.0%
Q1 2017$2,013,000
-24.0%
24,275
-27.3%
0.00%
-20.0%
Q4 2016$2,649,000
+13.3%
33,4000.0%0.01%0.0%
Q3 2016$2,338,000
+80.5%
33,4000.0%0.01%
+66.7%
Q2 2016$1,295,00033,4000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders